Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Pelagos Insurance Capital Limited share price today

Pelagos Insurance Capital Limited · PLGO · Financials · Insurance - Diversified · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Pelagos Insurance Capital Limited share price: $27.42 at the close on 4 November 2026, +45.4% in a year.

Turning aroundBusiness trend from the last 12 quarters
$27.42Price +45.4% in a year
1.0×P/BV higher than 100% of the last 3.3 years
$650 MRevenue (Jun 2026) +10.3% on a year ago
$44.4 MProfit (Jun 2026) +125.4% on a year ago
6.8%Net margin +3.5 points on a year ago
18%ROE FY25
2.41%ROA latest

Pelagos Insurance Capital Limited's earnings have grown faster than its share price. Earnings per share grew +115.3% in a year while the price moved +45.4%.

The main question: yearly earnings per share moved +115.3% while the share price moved +45.4%.

The price has been rising for 43 weeks, and the P/BV is higher than 100% of its own last 3.3 years. Over the last four quarters, results have been improving, with profit +125.4% on a year earlier, with the net margin at 6.8%. What will decide it: whether the price catches up with earnings that have already grown.

What is the Pelagos Insurance Capital Limited share price today?

Pelagos Insurance Capital Limited's share price was $27.42 at the close on 4 November 2026. It has been rising for 43 weeks. That is 21.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between $18 and $27, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Pelagos Insurance Capital Limited is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 2 weeks in a row.

1Y

Nov 2026: $27.42, 21.9% above its 200-day average. The price has been rising for 43 weeks.

  • Price $27.42
  • 50-day avg $24.84
  • 200-day avg $22.49
Nov 2026: $27.42, 21.9% above its 200-day average. The price has been rising for 43 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$17.98$17.78$16.61
7 Nov 2025$18.86$17.90$16.65
14 Nov 2025$18.37$18.04$16.71
21 Nov 2025$18.84$18.17$16.76
28 Nov 2025$19.04$18.30$16.81
5 Dec 2025$18.09$18.39$16.86
12 Dec 2025$19.03$18.48$16.96
19 Dec 2025$19.21$18.57$17.07
26 Dec 2025$19.48$18.65$17.16
2 Jan 2026$19.38$18.78$17.25
9 Jan 2026$19.02$18.88$17.34
16 Jan 2026$18.35$18.95$17.40
23 Jan 2026$18.63$18.93$17.45
30 Jan 2026$19.04$18.94$17.53
6 Feb 2026$19.40$19.00$17.61
13 Feb 2026$19.65$19.06$17.69
20 Feb 2026$20.04$19.19$17.76
27 Feb 2026$19.06$19.28$17.83
6 Mar 2026$18.62$19.25$17.88
13 Mar 2026$18.70$19.17$17.92
20 Mar 2026$18.84$19.12$17.96
27 Mar 2026$18.75$19.13$18.00
2 Apr 2026$19.14$19.18$18.05
10 Apr 2026$20.05$19.28$18.14
17 Apr 2026$20.97$19.40$18.24
24 Apr 2026$20.96$19.55$18.36
1 May 2026$21.21$19.68$18.49
8 May 2026$20.91$19.78$18.62
15 May 2026$23.16$20.01$18.77
22 May 2026$22.79$20.46$18.97
29 May 2026$21.58$20.71$19.08
5 Jun 2026$21.81$20.97$19.19
12 Jun 2026$23.65$21.37$19.33
18 Jun 2026$22.94$21.68$19.45
26 Jun 2026$24.74$22.05$19.61
2 Jul 2026$25.56$22.39$19.76
10 Jul 2026$25.07$22.77$19.94
17 Jul 2026$25.40$23.20$20.14
24 Jul 2026$25.58$23.66$20.32
31 Jul 2026$25.29$23.93$20.50
7 Aug 2026$25.03$24.19$20.67
14 Aug 2026$23.84$24.43$20.82
21 Aug 2026$24.04$24.58$20.96
28 Aug 2026$24.52$24.66$21.10
4 Sep 2026$25.32$24.82$21.26
11 Sep 2026$25.20$24.84$21.39
18 Sep 2026$23.54$24.78$21.52
25 Sep 2026$23.96$24.64$21.66
2 Oct 2026$24.25$24.51$21.79
9 Oct 2026$24.28$24.36$21.91
16 Oct 2026$25.36$24.31$22.04
23 Oct 2026$25.88$24.45$22.19
30 Oct 2026$26.33$24.69$22.37
4 Nov 2026$27.42$24.84$22.49
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $27.42, 21.9% above its 200-day average. The price has been rising for 43 weeks.

  • Price $27.42
  • 50-day avg $24.84
  • 200-day avg $22.49
Nov 2026: $27.42, 21.9% above its 200-day average. The price has been rising for 43 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$14.17$14.43–
10 Nov 2023$14.01$14.38–
17 Nov 2023$13.94$14.34–
24 Nov 2023$12.46$14.19–
1 Dec 2023$12.44$13.93–
8 Dec 2023$12.28$13.71–
15 Dec 2023$12.06$13.48–
22 Dec 2023$12.81$13.28–
29 Dec 2023$12.67$13.17–
5 Jan 2024$12.26$13.03–
12 Jan 2024$12.55$12.84–
19 Jan 2024$12.49$12.71–
26 Jan 2024$12.72$12.57–
2 Feb 2024$12.77$12.47–
9 Feb 2024$13.10$12.52–
16 Feb 2024$13.33$12.61–
23 Feb 2024$14.24$12.71–
1 Mar 2024$16.91$13.00–
8 Mar 2024$17.83$13.49–
15 Mar 2024$18.65$14.07–
22 Mar 2024$18.57$14.74–
28 Mar 2024$19.48$15.26–
5 Apr 2024$19.14$15.93–
12 Apr 2024$18.50$16.52–
19 Apr 2024$19.08$17.12$14.43
26 Apr 2024$19.50$17.76$14.57
3 May 2024$18.69$18.32$14.70
10 May 2024$18.48$18.74$14.83
17 May 2024$18.53$18.84$14.95
24 May 2024$16.24$18.71$15.03
31 May 2024$16.58$18.49$15.08
7 Jun 2024$15.73$18.20$15.14
14 Jun 2024$15.46$17.85$15.18
21 Jun 2024$16.16$17.62$15.21
28 Jun 2024$16.31$17.40$15.25
5 Jul 2024$15.90$17.17$15.29
12 Jul 2024$17.43$16.90$15.34
19 Jul 2024$17.54$16.80$15.42
26 Jul 2024$17.48$16.66$15.49
2 Aug 2024$16.93$16.58$15.56
9 Aug 2024$17.21$16.64$15.63
16 Aug 2024$18.60$16.82$15.72
23 Aug 2024$18.74$17.07$15.83
30 Aug 2024$18.52$17.33$15.94
6 Sep 2024$18.26$17.48$16.03
13 Sep 2024$17.60$17.62$16.15
20 Sep 2024$17.93$17.76$16.29
27 Sep 2024$18.22$17.83$16.44
4 Oct 2024$18.64$17.92$16.59
11 Oct 2024$18.13$17.93$16.72
18 Oct 2024$17.78$18.06$16.85
25 Oct 2024$17.35$18.04$16.98
1 Nov 2024$17.02$17.94$17.10
8 Nov 2024$18.57$17.88$17.24
15 Nov 2024$19.65$17.98$17.40
22 Nov 2024$20.39$18.21$17.58
29 Nov 2024$20.53$18.43$17.73
6 Dec 2024$19.73$18.61$17.90
13 Dec 2024$19.08$18.74$18.02
20 Dec 2024$17.95$18.77$18.03
27 Dec 2024$17.61$18.74$18.02
3 Jan 2025$17.29$18.75$18.00
10 Jan 2025$16.13$18.68$17.96
17 Jan 2025$16.63$18.61$17.90
24 Jan 2025$16.48$18.47$17.84
31 Jan 2025$16.50$18.22$17.80
7 Feb 2025$16.79$17.87$17.74
14 Feb 2025$16.21$17.47$17.66
21 Feb 2025$14.52$17.12$17.60
28 Feb 2025$14.71$16.65$17.49
7 Mar 2025$15.00$16.37$17.42
14 Mar 2025$15.14$16.06$17.36
21 Mar 2025$15.59$15.87$17.34
28 Mar 2025$16.20$15.84$17.35
4 Apr 2025$15.47$15.82$17.36
11 Apr 2025$15.66$15.68$17.34
17 Apr 2025$16.18$15.65$17.33
25 Apr 2025$16.19$15.61$17.34
2 May 2025$16.65$15.63$17.31
9 May 2025$17.02$15.85$17.29
16 May 2025$17.57$16.06$17.29
23 May 2025$16.44$16.29$17.29
30 May 2025$17.48$16.43$17.29
6 Jun 2025$17.49$16.61$17.28
13 Jun 2025$16.22$16.65$17.24
20 Jun 2025$15.93$16.71$17.19
27 Jun 2025$16.27$16.72$17.14
3 Jul 2025$16.19$16.75$17.12
11 Jul 2025$15.72$16.70$17.07
18 Jul 2025$15.98$16.64$17.01
25 Jul 2025$15.60$16.52$16.95
1 Aug 2025$14.87$16.29$16.88
8 Aug 2025$16.79$16.22$16.83
15 Aug 2025$16.28$16.16$16.82
22 Aug 2025$17.54$16.18$16.82
29 Aug 2025$17.48$16.26$16.80
5 Sep 2025$17.42$16.39$16.77
12 Sep 2025$17.53$16.48$16.70
19 Sep 2025$17.63$16.63$16.63
26 Sep 2025$17.53$16.79$16.56
3 Oct 2025$18.10$16.99$16.52
10 Oct 2025$18.32$17.31$16.54
17 Oct 2025$17.91$17.58$16.55
24 Oct 2025$18.28$17.69$16.57
31 Oct 2025$17.98$17.78$16.61
7 Nov 2025$18.86$17.90$16.65
14 Nov 2025$18.37$18.04$16.71
21 Nov 2025$18.84$18.17$16.76
28 Nov 2025$19.04$18.30$16.81
5 Dec 2025$18.09$18.39$16.86
12 Dec 2025$19.03$18.48$16.96
19 Dec 2025$19.21$18.57$17.07
26 Dec 2025$19.48$18.65$17.16
2 Jan 2026$19.38$18.78$17.25
9 Jan 2026$19.02$18.88$17.34
16 Jan 2026$18.35$18.95$17.40
23 Jan 2026$18.63$18.93$17.45
30 Jan 2026$19.04$18.94$17.53
6 Feb 2026$19.40$19.00$17.61
13 Feb 2026$19.65$19.06$17.69
20 Feb 2026$20.04$19.19$17.76
27 Feb 2026$19.06$19.28$17.83
6 Mar 2026$18.62$19.25$17.88
13 Mar 2026$18.70$19.17$17.92
20 Mar 2026$18.84$19.12$17.96
27 Mar 2026$18.75$19.13$18.00
2 Apr 2026$19.14$19.18$18.05
10 Apr 2026$20.05$19.28$18.14
17 Apr 2026$20.97$19.40$18.24
24 Apr 2026$20.96$19.55$18.36
1 May 2026$21.21$19.68$18.49
8 May 2026$20.91$19.78$18.62
15 May 2026$23.16$20.01$18.77
22 May 2026$22.79$20.46$18.97
29 May 2026$21.58$20.71$19.08
5 Jun 2026$21.81$20.97$19.19
12 Jun 2026$23.65$21.37$19.33
18 Jun 2026$22.94$21.68$19.45
26 Jun 2026$24.74$22.05$19.61
2 Jul 2026$25.56$22.39$19.76
10 Jul 2026$25.07$22.77$19.94
17 Jul 2026$25.40$23.20$20.14
24 Jul 2026$25.58$23.66$20.32
31 Jul 2026$25.29$23.93$20.50
7 Aug 2026$25.03$24.19$20.67
14 Aug 2026$23.84$24.43$20.82
21 Aug 2026$24.04$24.58$20.96
28 Aug 2026$24.52$24.66$21.10
4 Sep 2026$25.32$24.82$21.26
11 Sep 2026$25.20$24.84$21.39
18 Sep 2026$23.54$24.78$21.52
25 Sep 2026$23.96$24.64$21.66
2 Oct 2026$24.25$24.51$21.79
9 Oct 2026$24.28$24.36$21.91
16 Oct 2026$25.36$24.31$22.04
23 Oct 2026$25.88$24.45$22.19
30 Oct 2026$26.33$24.69$22.37
4 Nov 2026$27.42$24.84$22.49
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

Price stage: Sideways from Oct 2025 to Jan 2026; Rising from Jan 2026 to Nov 2026.

Price stage: Rising from Nov 2024 to Dec 2024; Sideways from Dec 2024 to Jun 2025; Falling from Jun 2025 to Aug 2025; Sideways from Aug 2025 to Jan 2026; Rising from Jan 2026 to Nov 2026.

Week by week since 2023: did it beat the S&P 500 over the past 13 weeks?

Ahead in 92 of 163 weeks

Week by week since 2023: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
30 Jun 2023no S&P 500 reading
7 Jul 2023no S&P 500 reading
14 Jul 2023no S&P 500 reading
21 Jul 2023no S&P 500 reading
28 Jul 2023no S&P 500 reading
4 Aug 2023no S&P 500 reading
11 Aug 2023no S&P 500 reading
18 Aug 2023no S&P 500 reading
25 Aug 2023no S&P 500 reading
1 Sep 2023no S&P 500 reading
8 Sep 2023no S&P 500 reading
15 Sep 2023no S&P 500 reading
22 Sep 2023no S&P 500 reading
29 Sep 2023+11.1%
6 Oct 2023+5.3%
13 Oct 2023+7.5%
20 Oct 2023+8.3%
27 Oct 2023+9.8%
3 Nov 2023+8.4%
10 Nov 2023+5.3%
17 Nov 2023+0.9%
24 Nov 2023−18.2%
1 Dec 2023−16.4%
8 Dec 2023−16.4%
15 Dec 2023−22.9%
22 Dec 2023−22.3%
29 Dec 2023−24.9%
5 Jan 2024−23.2%
12 Jan 2024−21.8%
19 Jan 2024−25.0%
26 Jan 2024−26.8%
2 Feb 2024−23.6%
9 Feb 2024−20.2%
16 Feb 2024−15.2%
23 Feb 2024+2.7%
1 Mar 2024+24.2%
8 Mar 2024+34.0%
15 Mar 2024+46.0%
22 Mar 2024+34.9%
28 Mar 2024+43.7%
5 Apr 2024+45.3%
12 Apr 2024+40.2%
19 Apr 2024+50.1%
26 Apr 2024+49.0%
3 May 2024+42.9%
10 May 2024+37.2%
17 May 2024+33.0%
24 May 2024+9.8%
31 May 2024−4.8%
7 Jun 2024−16.1%
14 Jun 2024−23.6%
21 Jun 2024−17.4%
28 Jun 2024−20.3%
5 Jul 2024−23.9%
12 Jul 2024−15.4%
19 Jul 2024−18.9%
26 Jul 2024−17.5%
2 Aug 2024−13.6%
9 Aug 2024−9.2%
16 Aug 2024−4.3%
23 Aug 2024+9.2%
30 Aug 2024+4.8%
6 Sep 2024+14.9%
13 Sep 2024+10.3%
20 Sep 2024+6.6%
27 Sep 2024+6.7%
4 Oct 2024+13.9%
11 Oct 2024+0.5%
18 Oct 2024−5.1%
25 Oct 2024−7.1%
1 Nov 2024−6.6%
8 Nov 2024−4.3%
15 Nov 2024+0.0%
22 Nov 2024+2.9%
29 Nov 2024+4.0%
6 Dec 2024−4.4%
13 Dec 2024+0.9%
20 Dec 2024−3.9%
27 Dec 2024−7.5%
3 Jan 2025−10.6%
10 Jan 2025−11.2%
17 Jan 2025−8.7%
24 Jan 2025−10.0%
31 Jan 2025−8.4%
7 Feb 2025−10.0%
14 Feb 2025−21.6%
21 Feb 2025−29.5%
28 Feb 2025−27.0%
7 Mar 2025−18.7%
14 Mar 2025−13.8%
21 Mar 2025−8.6%
28 Mar 2025−1.4%
4 Apr 2025+4.1%
11 Apr 2025+5.1%
17 Apr 2025+9.2%
25 Apr 2025+7.7%
2 May 2025+6.7%
9 May 2025+7.4%
16 May 2025+10.9%
23 May 2025+16.7%
30 May 2025+19.6%
6 Jun 2025+12.6%
13 Jun 2025+1.1%
20 Jun 2025−3.2%
27 Jun 2025−10.2%
3 Jul 2025−19.1%
11 Jul 2025−16.4%
18 Jul 2025−20.5%
25 Jul 2025−19.3%
1 Aug 2025−20.4%
8 Aug 2025−14.3%
15 Aug 2025−15.6%
22 Aug 2025−4.7%
29 Aug 2025−9.4%
5 Sep 2025−8.4%
12 Sep 2025−2.0%
19 Sep 2025−1.0%
26 Sep 2025+0.1%
3 Oct 2025+4.8%
10 Oct 2025+11.8%
17 Oct 2025+6.2%
24 Oct 2025+10.9%
31 Oct 2025+11.2%
7 Nov 2025+7.0%
14 Nov 2025+8.4%
21 Nov 2025+5.3%
28 Nov 2025+3.0%
5 Dec 2025−2.1%
12 Dec 2025+4.9%
19 Dec 2025+6.4%
26 Dec 2025+6.8%
2 Jan 2026+5.0%
9 Jan 2026−2.5%
16 Jan 2026−1.6%
23 Jan 2026+0.1%
30 Jan 2026+4.4%
6 Feb 2026−0.1%
13 Feb 2026+5.5%
20 Feb 2026+1.8%
27 Feb 2026−0.3%
6 Mar 2026+4.9%
13 Mar 2026+1.1%
20 Mar 2026+2.8%
27 Mar 2026+4.4%
2 Apr 2026+2.8%
10 Apr 2026+7.5%
17 Apr 2026+11.6%
24 Apr 2026+8.9%
1 May 2026+7.3%
8 May 2026+1.0%
15 May 2026+9.4%
22 May 2026+5.6%
29 May 2026+2.9%
5 Jun 2026+7.4%
12 Jun 2026+14.5%
18 Jun 2026+6.6%
26 Jun 2026+17.0%
2 Jul 2026+20.0%
10 Jul 2026+13.9%
17 Jul 2026+16.5%
24 Jul 2026+18.5%
31 Jul 2026+15.6%
7 Aug 2026+14.9%
14 Aug 2026−2.1%
21 Aug 2026+2.8%
28 Aug 2026+11.9%
4 Sep 2026+11.7%
11 Sep 2026+3.5%
18 Sep 2026+0.6%
25 Sep 2026−9.0%
2 Oct 2026−8.5%
9 Oct 2026−6.3%
16 Oct 2026−2.8%
23 Oct 2026−1.7%
30 Oct 2026+2.9%
4 Nov 2026+10.4%
Each bar is one week, from 2023 to now (163 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 3.3 years the share price moved +101% while the S&P 500 moved +73%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Pelagos Insurance Capital Limited pay?

Pelagos Insurance Capital Limited paid $0.60 per share over the last four reported quarters. The most recent declaration was $0.15 for Jun 2026. At today's price of $27.42 that is a yield of 2.19%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.15 (Jun 2026)

  • Dividend per share $0.15
Dividend per share each quarter: latest $0.15 (Jun 2026)
QuarterDividend per share
Mar 2024$0.10
Jun 2024$0.10
Sep 2024$0.10
Dec 2024$0.10
Mar 2025$0.10
Jun 2025$0.10
Sep 2025$0.15
Dec 2025$0.15
Mar 2026$0.15
Jun 2026$0.15
Declared dividend per share, $ a share, each reported quarter. 10 quarters on file.

Which stock lists is Pelagos Insurance Capital Limited on?

Pelagos Insurance Capital Limited is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Pelagos Insurance Capital Limited profitable?

Pelagos Insurance Capital Limited earned $44.4 M of net profit in the Jun 2026 quarter, +125.4% on the same quarter a year earlier. Full-year FY25 profit was $226 M. Over 4 years profit has grown 34.8% a year on average. That is 6.8% of the quarter's revenue. The same quarter a year earlier earned $19.7 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

2 of the last 12 reported quarters were loss-making.

For the full year, FY25 profit was $226 M (+99.0% on the year before).

FY25 profit $226 M (+99.0% on the year before), 34.8% a year over 4 years

  • Net profit $226 M
FY25 profit $226 M (+99.0% on the year before), 34.8% a year over 4 years
QuarterNet profit
FY21$68.3 M
FY22$52.6 M
FY23$2.1 B
FY24$113 M
FY25$226 M

Growth on a year earlier

  • Growth on a year earlier 99%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−23%
FY233,954.2%
FY24−94.7%
FY2599%
Top: net profit each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $44.4 M (+125.4% on a year earlier)

  • Net profit (quarterly) $44.4 M
Jun 2026: $44.4 M (+125.4% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023$87.7 M
Dec 2023$228 M
Mar 2024$81.2 M
Jun 2024$53.7 M
Sep 2024$101 M
Dec 2024−$122 M
Mar 2025−$42.5 M
Jun 2025$19.7 M
Sep 2025$131 M
Dec 2025$118 M
Mar 2026$108 M
Jun 2026$44.4 M

Growth on a year earlier

  • Growth on a year earlier 125.4%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023–
Dec 202390.4%
Mar 2024−95.3%
Jun 2024−36%
Sep 202414.7%
Dec 2024−153.5%
Mar 2025−152.3%
Jun 2025−63.3%
Sep 202529.7%
Dec 2025–
Mar 2026–
Jun 2026125.4%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does Pelagos Insurance Capital Limited make, and is it growing?

Pelagos Insurance Capital Limited reported $650 M of income in the Jun 2026 quarter, +10.3% on the same quarter a year earlier. Over 4 years it has grown 20.3% a year on average. The last full year, FY25, came in at $2.5 B. The last four reported quarters add to $2.5 B.

For a bank, revenue is everything it earns: interest on its loans plus fees from its businesses.

FY25 revenue was $2.5 B, +3.3% on the year before.

FY25 revenue $2.5 B (+3.3% on the year before), 20.3% a year over 4 years

  • Revenue $2.5 B
FY25 revenue $2.5 B (+3.3% on the year before), 20.3% a year over 4 years
QuarterRevenue
FY21$1.2 B
FY22$1.5 B
FY23$2.0 B
FY24$2.4 B
FY25$2.5 B

Growth on a year earlier

  • Growth on a year earlier 3.3%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2226.3%
FY2329.7%
FY2423.7%
FY253.3%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $650 M (+10.3% on a year earlier)

  • Revenue (quarterly) $650 M
Jun 2026: $650 M (+10.3% on a year earlier)
QuarterRevenue (quarterly)
Sep 2023$538 M
Dec 2023$554 M
Mar 2024$520 M
Jun 2024$540 M
Sep 2024$686 M
Dec 2024$674 M
Mar 2025$658 M
Jun 2025$589 M
Sep 2025$652 M
Dec 2025$601 M
Mar 2026$611 M
Jun 2026$650 M

Growth on a year earlier

  • Growth on a year earlier 10.3%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 202324.2%
Dec 202329.1%
Mar 202426%
Jun 202419.2%
Sep 202427.6%
Dec 202421.7%
Mar 202526.6%
Jun 20259.1%
Sep 2025−5%
Dec 2025−10.8%
Mar 2026−7.3%
Jun 202610.3%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew −3.2% on average, against 20.3% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −3.6%, against +8.1% a year over the last 8 quarters (rolling over).

How much does Pelagos Insurance Capital Limited keep from what it earns?

Pelagos Insurance Capital Limited's net margin was 6.8% in the Jun 2026 quarter, 3.5 percentage points higher than the same quarter a year ago. Across 5 years it has been between 3.5% and 109.0%. The latest quarter is within that range.

Net margin is what the bank keeps from every $100 of revenue after every cost, provision for bad loans and tax. With big fee businesses in the mix, it is the clearest margin we can read for this bank.

Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

FY25: 9.0%, within a range of 3.5% to 109.0% over 5 years

  • Net margin 9.0%
FY25: 9.0%, within a range of 3.5% to 109.0% over 5 years
QuarterNet margin
FY215.7%
FY223.5%
FY23109%
FY244.7%
FY259%

Change on the year before (points)

  • Change on the year before (points) +4.3 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−2.2 pts
FY23+105.5 pts
FY24−104.3 pts
FY25+4.3 pts
Net margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: net margin 6.8% (+3.5 points on a year earlier)

  • Net margin 6.8%
Jun 2026: net margin 6.8% (+3.5 points on a year earlier)
QuarterNet margin
Sep 202316.3%
Dec 202341.2%
Mar 202415.6%
Jun 20249.9%
Sep 202414.7%
Dec 2024−18.1%
Mar 2025−6.5%
Jun 20253.3%
Sep 202520%
Dec 202519.6%
Mar 202617.7%
Jun 20266.8%

Change on a year earlier (points)

  • Change on a year earlier (points) +3.5 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023+37.7 pts
Dec 2023+13.2 pts
Mar 2024−404.2 pts
Jun 2024−8.6 pts
Sep 2024−1.6 pts
Dec 2024−59.3 pts
Mar 2025−22.1 pts
Jun 2025−6.6 pts
Sep 2025+5.3 pts
Dec 2025+37.7 pts
Mar 2026+24.2 pts
Jun 2026+3.5 pts
Top: quarterly net margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Net profit as a share of total revenue, each quarter.

How many of Pelagos Insurance Capital Limited's loans have gone bad?

Pelagos Insurance Capital Limited does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report.

Gross NPA is the share of the loan book where repayments have stopped. Net NPA is what is left after the money the lender has already set aside for those loans. Falling is good; rising is a warning.

Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up.

How fast is Pelagos Insurance Capital Limited's loan book growing?

Pelagos Insurance Capital Limited's revenue was $2.5 B in FY25, +3.3% on the year before, so the loan book is growing. The latest quarter was +10.3% on a year earlier. The net margin on that income is 6.8%, +3.5 percentage points on a year ago.

We read the loan book through revenue: when the book and the businesses grow, revenue grows with them. It is only a rough guide, because interest-rate changes and fee swings can move it a few points in any year.

Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year.

FY25: revenue $2.5 B (+3.3% on the year before), net margin 9.0%

  • Revenue $2.5 B
FY25: revenue $2.5 B (+3.3% on the year before), net margin 9.0%
QuarterRevenue
FY21$1.2 B
FY22$1.5 B
FY23$2.0 B
FY24$2.4 B
FY25$2.5 B

Net margin

  • Net margin 9%
Net margin
QuarterNet margin
FY215.7%
FY223.5%
FY23109%
FY244.7%
FY259%
Top: revenue each year, $ B. Below: net margin, %. 5-year window. A grey bar is lower than the year before.

In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch.

What is Pelagos Insurance Capital Limited's P/BV ratio, and how does it compare with its own history?

Pelagos Insurance Capital Limited's P/BV is 1.0×, about the highest it has ever been. Its usual P/BV (the middle reading) is 0.8×, over 3.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

For a bank or lender we compare the price with book value, the net worth on its balance sheet. P/BV is how many dollars the market pays for each $1 of that net worth. Below 1× means the market values it at less than its net worth.

P/BV 1.0× against a usual 0.8×: about the highest it has ever been

  • P/BV 0.90×
  • Median 0.78×
P/BV 1.0× against a usual 0.8×: about the highest it has ever been
WeekP/BVMedian
30 Jun 20230.76×0.78×
7 Jul 20230.77×0.78×
14 Jul 20230.76×0.78×
21 Jul 20230.77×0.78×
28 Jul 20230.78×0.78×
4 Aug 20230.75×0.78×
11 Aug 20230.75×0.78×
18 Aug 20230.75×0.78×
25 Aug 20230.82×0.78×
1 Sep 20230.81×0.78×
8 Sep 20230.79×0.78×
15 Sep 20230.81×0.78×
22 Sep 20230.82×0.78×
29 Sep 20230.82×0.78×
6 Oct 20230.78×0.78×
13 Oct 20230.77×0.78×
20 Oct 20230.76×0.78×
27 Oct 20230.76×0.78×
3 Nov 20230.77×0.78×
10 Nov 20230.76×0.78×
17 Nov 20230.76×0.78×
24 Nov 20230.68×0.78×
1 Dec 20230.68×0.78×
8 Dec 20230.67×0.78×
15 Dec 20230.66×0.78×
22 Dec 20230.70×0.78×
29 Dec 20230.69×0.78×
5 Jan 20240.59×0.78×
12 Jan 20240.60×0.78×
19 Jan 20240.60×0.78×
26 Jan 20240.61×0.78×
2 Feb 20240.61×0.78×
9 Feb 20240.63×0.78×
16 Feb 20240.64×0.78×
23 Feb 20240.69×0.78×
1 Mar 20240.81×0.78×
8 Mar 20240.86×0.78×
15 Mar 20240.90×0.78×
22 Mar 20240.89×0.78×
28 Mar 20240.90×0.78×
5 Apr 20240.89×0.78×
12 Apr 20240.86×0.78×
19 Apr 20240.89×0.78×
26 Apr 20240.90×0.78×
3 May 20240.87×0.78×
10 May 20240.86×0.78×
17 May 20240.87×0.78×
24 May 20240.76×0.78×
31 May 20240.77×0.78×
7 Jun 20240.73×0.78×
14 Jun 20240.72×0.78×
21 Jun 20240.75×0.78×
28 Jun 20240.76×0.78×
5 Jul 20240.73×0.78×
12 Jul 20240.80×0.78×
19 Jul 20240.80×0.78×
26 Jul 20240.80×0.78×
2 Aug 20240.78×0.78×
9 Aug 20240.79×0.78×
16 Aug 20240.85×0.78×
23 Aug 20240.86×0.78×
30 Aug 20240.85×0.78×
6 Sep 20240.84×0.78×
13 Sep 20240.81×0.78×
20 Sep 20240.82×0.78×
27 Sep 20240.84×0.78×
4 Oct 20240.79×0.78×
11 Oct 20240.77×0.78×
18 Oct 20240.75×0.78×
25 Oct 20240.74×0.78×
1 Nov 20240.72×0.78×
8 Nov 20240.79×0.78×
15 Nov 20240.83×0.78×
22 Nov 20240.87×0.78×
29 Nov 20240.87×0.78×
6 Dec 20240.84×0.78×
13 Dec 20240.81×0.78×
20 Dec 20240.76×0.78×
27 Dec 20240.75×0.78×
3 Jan 20250.79×0.78×
10 Jan 20250.74×0.78×
17 Jan 20250.76×0.78×
24 Jan 20250.75×0.78×
31 Jan 20250.75×0.78×
7 Feb 20250.77×0.78×
14 Feb 20250.74×0.78×
21 Feb 20250.66×0.78×
28 Feb 20250.67×0.78×
7 Mar 20250.68×0.78×
14 Mar 20250.69×0.78×
21 Mar 20250.71×0.78×
28 Mar 20250.74×0.78×
4 Apr 20250.71×0.78×
11 Apr 20250.72×0.78×
17 Apr 20250.75×0.78×
25 Apr 20250.75×0.78×
2 May 20250.77×0.78×
9 May 20250.79×0.78×
16 May 20250.81×0.78×
23 May 20250.76×0.78×
30 May 20250.81×0.78×
6 Jun 20250.81×0.78×
13 Jun 20250.75×0.78×
20 Jun 20250.73×0.78×
27 Jun 20250.75×0.78×
3 Jul 20250.73×0.78×
11 Jul 20250.71×0.78×
18 Jul 20250.72×0.78×
25 Jul 20250.70×0.78×
1 Aug 20250.67×0.78×
8 Aug 20250.76×0.78×
15 Aug 20250.73×0.78×
22 Aug 20250.79×0.78×
29 Aug 20250.79×0.78×
5 Sep 20250.79×0.78×
12 Sep 20250.79×0.78×
19 Sep 20250.80×0.78×
26 Sep 20250.79×0.78×
3 Oct 20250.77×0.78×
10 Oct 20250.78×0.78×
17 Oct 20250.76×0.78×
24 Oct 20250.78×0.78×
31 Oct 20250.77×0.78×
7 Nov 20250.80×0.78×
14 Nov 20250.78×0.78×
21 Nov 20250.80×0.78×
28 Nov 20250.81×0.78×
5 Dec 20250.77×0.78×
12 Dec 20250.81×0.78×
19 Dec 20250.82×0.78×
26 Dec 20250.83×0.78×
2 Jan 20260.78×0.78×
9 Jan 20260.77×0.78×
16 Jan 20260.74×0.78×
23 Jan 20260.75×0.78×
30 Jan 20260.77×0.78×
6 Feb 20260.78×0.78×
13 Feb 20260.79×0.78×
20 Feb 20260.81×0.78×
27 Feb 20260.77×0.78×
6 Mar 20260.75×0.78×
13 Mar 20260.75×0.78×
20 Mar 20260.76×0.78×
27 Mar 20260.76×0.78×
2 Apr 20260.73×0.78×
10 Apr 20260.76×0.78×
17 Apr 20260.80×0.78×
24 Apr 20260.80×0.78×
1 May 20260.80×0.78×
8 May 20260.79×0.78×
15 May 20260.88×0.78×
22 May 20260.86×0.78×
29 May 20260.82×0.78×
5 Jun 20260.83×0.78×
12 Jun 20260.90×0.78×
18 Jun 20260.87×0.78×
26 Jun 20260.90×0.78×
2 Jul 20260.90×0.78×
10 Jul 20260.90×0.78×
17 Jul 20260.90×0.78×
24 Jul 20260.90×0.78×
31 Jul 20260.90×0.78×
7 Aug 20260.90×0.78×
14 Aug 20260.89×0.78×
21 Aug 20260.90×0.78×
28 Aug 20260.90×0.78×
4 Sep 20260.90×0.78×
11 Sep 20260.90×0.78×
18 Sep 20260.88×0.78×
25 Sep 20260.89×0.78×
2 Oct 20260.90×0.78×
9 Oct 20260.90×0.78×
16 Oct 20260.90×0.78×
23 Oct 20260.90×0.78×
30 Oct 20260.90×0.78×
4 Nov 20260.90×0.78×

Book value per share

  • Book value per share $26.84
Book value per share
WeekBook value per share
30 Jun 2023$17.88
7 Jul 2023$17.88
14 Jul 2023$17.88
21 Jul 2023$17.88
28 Jul 2023$17.88
4 Aug 2023$17.88
11 Aug 2023$17.88
18 Aug 2023$17.88
25 Aug 2023$17.88
1 Sep 2023$17.88
8 Sep 2023$17.88
15 Sep 2023$17.88
22 Sep 2023$17.88
29 Sep 2023$17.88
6 Oct 2023$17.88
13 Oct 2023$17.88
20 Oct 2023$17.88
27 Oct 2023$17.88
3 Nov 2023$17.88
10 Nov 2023$17.88
17 Nov 2023$17.88
24 Nov 2023$17.88
1 Dec 2023$17.88
8 Dec 2023$17.88
15 Dec 2023$17.88
22 Dec 2023$17.88
29 Dec 2023$18.32
5 Jan 2024$18.32
12 Jan 2024$18.32
19 Jan 2024$18.32
26 Jan 2024$18.32
2 Feb 2024$18.32
9 Feb 2024$18.32
16 Feb 2024$18.32
23 Feb 2024$18.32
1 Mar 2024$18.32
8 Mar 2024$18.32
15 Mar 2024$18.32
22 Mar 2024$18.32
28 Mar 2024$20.78
5 Apr 2024$20.78
12 Apr 2024$20.78
19 Apr 2024$20.78
26 Apr 2024$20.78
3 May 2024$20.78
10 May 2024$20.78
17 May 2024$20.78
24 May 2024$20.78
31 May 2024$20.78
7 Jun 2024$20.78
14 Jun 2024$20.78
21 Jun 2024$20.78
28 Jun 2024$21.41
5 Jul 2024$21.41
12 Jul 2024$21.41
19 Jul 2024$21.41
26 Jul 2024$21.41
2 Aug 2024$21.41
9 Aug 2024$21.41
16 Aug 2024$21.41
23 Aug 2024$21.41
30 Aug 2024$21.41
6 Sep 2024$21.41
13 Sep 2024$21.41
20 Sep 2024$21.41
27 Sep 2024$21.81
4 Oct 2024$21.81
11 Oct 2024$21.81
18 Oct 2024$21.81
25 Oct 2024$21.81
1 Nov 2024$21.81
8 Nov 2024$21.81
15 Nov 2024$21.81
22 Nov 2024$21.81
29 Nov 2024$21.81
6 Dec 2024$21.81
13 Dec 2024$21.81
20 Dec 2024$21.81
27 Dec 2024$23.56
3 Jan 2025$23.56
10 Jan 2025$23.56
17 Jan 2025$23.56
24 Jan 2025$23.56
31 Jan 2025$23.56
7 Feb 2025$23.56
14 Feb 2025$23.56
21 Feb 2025$23.56
28 Feb 2025$23.56
7 Mar 2025$23.56
14 Mar 2025$23.56
21 Mar 2025$23.56
28 Mar 2025$21.91
4 Apr 2025$21.91
11 Apr 2025$21.91
17 Apr 2025$21.91
25 Apr 2025$21.91
2 May 2025$21.91
9 May 2025$21.91
16 May 2025$21.91
23 May 2025$21.91
30 May 2025$21.91
6 Jun 2025$21.91
13 Jun 2025$21.91
20 Jun 2025$21.91
27 Jun 2025$21.67
3 Jul 2025$21.67
11 Jul 2025$21.67
18 Jul 2025$21.67
25 Jul 2025$21.67
1 Aug 2025$21.67
8 Aug 2025$21.67
15 Aug 2025$21.67
22 Aug 2025$21.67
29 Aug 2025$21.67
5 Sep 2025$21.67
12 Sep 2025$21.67
19 Sep 2025$21.67
26 Sep 2025$22.16
3 Oct 2025$22.16
10 Oct 2025$22.16
17 Oct 2025$22.16
24 Oct 2025$22.16
31 Oct 2025$22.16
7 Nov 2025$22.16
14 Nov 2025$22.16
21 Nov 2025$22.16
28 Nov 2025$22.16
5 Dec 2025$22.16
12 Dec 2025$22.16
19 Dec 2025$22.16
26 Dec 2025$23.45
2 Jan 2026$23.45
9 Jan 2026$23.45
16 Jan 2026$23.45
23 Jan 2026$23.45
30 Jan 2026$23.45
6 Feb 2026$23.45
13 Feb 2026$23.45
20 Feb 2026$23.45
27 Feb 2026$23.45
6 Mar 2026$23.45
13 Mar 2026$23.45
20 Mar 2026$23.45
27 Mar 2026$24.83
2 Apr 2026$24.83
10 Apr 2026$24.83
17 Apr 2026$24.83
24 Apr 2026$24.83
1 May 2026$24.83
8 May 2026$24.83
15 May 2026$24.83
22 May 2026$24.83
29 May 2026$24.83
5 Jun 2026$24.83
12 Jun 2026$24.83
18 Jun 2026$24.83
26 Jun 2026$26.36
2 Jul 2026$26.36
10 Jul 2026$26.36
17 Jul 2026$26.36
24 Jul 2026$26.36
31 Jul 2026$26.36
7 Aug 2026$26.36
14 Aug 2026$26.36
21 Aug 2026$26.36
28 Aug 2026$26.36
4 Sep 2026$26.36
11 Sep 2026$26.36
18 Sep 2026$26.36
25 Sep 2026$26.84
2 Oct 2026$26.84
9 Oct 2026$26.84
16 Oct 2026$26.84
23 Oct 2026$26.84
30 Oct 2026$26.84
4 Nov 2026$26.84
Top: P/BV each week. Below: book value per share, quarterly steps drawn, a step line that moves once a quarter; 3.3 years of history; short peaks above 0.9× are drawn at the top edge.
1.0×P/BV · higher than 100% of its last 3.3 years
0.21PEG · today, derived from 3-year earnings growth

Why the multiple is where it is: over the past year book value grew while the price moved +45.4%. The price ran ahead of book value, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved +24.6% a year; about +13.6% a year came from book-value growth and about +11.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the book value trend underneath matters more than the multiple.

Is the Pelagos Insurance Capital Limited business getting better or worse?

Pelagos Insurance Capital Limited's business is turning around. Profit growth has swung from −103.1% at its low to +99.0%, rising from a low 1 quarters ago, with ROE rising at 18.0%. This is based on 11 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +3.3% in FY25, profit +99.0%

  • Revenue growth 3.3%
Growth year by year: revenue +3.3% in FY25, profit +99.0%
QuarterRevenue growth
FY21–
FY2226.3%
FY2329.7%
FY2423.7%
FY253.3%

Profit growth, EPS growth

  • Profit growth 99%
  • EPS growth 115.3%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−23%−23.5%
FY23300%300%
FY24−94.7%−94.7%
FY2599%115.3%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn. Turnaround-year jumps are drawn at the edge (▲).

Three growth lines over twelve quarters: revenue rolling over

  • Revenue −3.6%
Three growth lines over twelve quarters: revenue rolling over
QuarterRevenue
Sep 2023–
Dec 202329.7%
Mar 202428.7%
Jun 202424.5%
Sep 202425.5%
Dec 202423.7%
Mar 202523.9%
Jun 202521.2%
Sep 202511.9%
Dec 20253.3%
Mar 2026−4.1%
Jun 2026−3.6%

Profit, EPS

  • Profit 99%
  • EPS 137.1%
Profit, EPS
QuarterProfitEPS
Sep 2023––
Dec 2023300%300%
Mar 2024−72.8%−73.9%
Jun 2024−75.5%−76.9%
Sep 2024−77.1%−77.7%
Dec 2024−94.7%−95.1%
Mar 2025−102.2%−103.4%
Jun 2025−109.8%−111%
Sep 2025−103.1%−101.5%
Dec 202599%137.1%
Mar 2026––
Jun 2026––
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROE: the return line, worked out each quarter

  • ROE 18%
ROE: the return line, worked out each quarter
QuarterROE
Sep 2023–
Dec 2023–
Mar 202419.1%
Jun 202417.8%
Sep 202417.6%
Dec 20244.6%
Mar 2025−0.4%
Jun 2025−1.9%
Sep 2025−0.6%
Dec 20259.4%
Mar 202616.7%
Jun 202618%
Net profit over the last 12 months as a share of equity at the quarter end, %.
FallingRevenue growth · latest −3.6%, range −4.1% to +29.7%
RecoveringProfit growth · latest +99.0%, range −109.8% to +3,954.2%
RecoveringEPS growth · latest +137.1%, range −111.0% to +9,514.6%
RisingROE · latest 18.0%, range −1.9% to 19.1%

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+3.3%+18.3%——
Profit+99.0%+62.5%——
EPS+115.3%+101.0%——
Stock price+45.4%+24.6%——
+10.3%Revenue growth (Jun 2026) · latest quarter against a year ago
+125.4%Profit growth (Jun 2026) · latest quarter against a year ago
20.3%Revenue, 4 years · yearly growth over the long run

How much does Pelagos Insurance Capital Limited earn on its equity and assets?

Pelagos Insurance Capital Limited earned a return on equity of 9% in FY25. Its lowest yearly reading on file was 3% in FY22. On its assets, every $100 earned about $2.41, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together.

Two numbers rate a bank: ROE, what it earns on shareholders’ money, and ROA, what it earns on all its assets. An ROE above about 13 to 15% is healthy; below that, net worth grows slowly.

That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is.

FY25: ROE 9%, ROA 1.70%, up from a FY22 low of 3%

  • ROE 9.4%
FY25: ROE 9%, ROA 1.70%, up from a FY22 low of 3%
QuarterROE
FY213.4%
FY222.6%
FY2387%
FY244.6%
FY259.4%

ROA

  • ROA 1.7%
ROA
QuarterROA
FY211.1%
FY220.9%
FY233.1%
FY241%
FY251.7%
Return on equity each year, % (top); return on assets, % (below). 5-year window. A lender is judged on ROE and ROA; return on capital used (ROIC) does not apply to a bank.

Jun 2026: ROE 18.6% (last 12 months), ROA 2.30%

  • ROE (12 months) 18.6%
Jun 2026: ROE 18.6% (last 12 months), ROA 2.30%
QuarterROE (12 months)
Sep 202317.3%
Dec 202316.9%
Mar 202439.6%
Jun 202413.1%
Sep 20248.5%
Dec 202415.6%
Mar 2025−19.2%
Jun 2025−7%
Sep 20253.3%
Dec 202522%
Mar 202619.6%
Jun 202618.6%

ROA (12 months)

  • ROA (12 months) 2.3%
ROA (12 months)
QuarterROA (12 months)
Sep 20232.6%
Dec 20232.6%
Mar 20243.5%
Jun 20242.4%
Sep 20241.6%
Dec 20242.8%
Mar 2025−2.9%
Jun 2025−0.8%
Sep 20250.6%
Dec 20253.5%
Mar 20263.1%
Jun 20262.3%
Return on equity over the last 12 months (top) and on assets (below), each quarter, %. Last 12 quarters, lined up with the yearly figure.

Why ROE moved: profit grew 34.8% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low.

Does Pelagos Insurance Capital Limited have too much debt?

For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead.

For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here.

What is the Pelagos Insurance Capital Limited shareholding pattern?

6.3% of Pelagos Insurance Capital Limited's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

6.3%Short interest · of the tradable float
5.6Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Pelagos Insurance Capital Limited from balance-sheet trouble?

For Pelagos Insurance Capital Limited, the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does Pelagos Insurance Capital Limited rank in its industry?

67.5 out of 100, rank 3 of 10 in Insurance - Diversified, with 69% of the evidence available.

Pelagos Insurance Capital Limited scores 67.5 out of 100 against the 10 companies it is compared with in Insurance - Diversified, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 18.8 + 15.4 + 16.2 + 17.1 = 67.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector.

Which companies is Pelagos Insurance Capital Limited compared with?

Pelagos Insurance Capital Limited ranks 3 of 10 Insurance - Diversified companies on the 4-Factor Sector Score, with 67.5 out of 100.

  1. 1Exzeo Group, Inc.XZO · turning · Most evidence points up · 74% evidence70.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.0/35 · Income 25% · Profit 52.7% · 81% evidenceCapital efficiency 19.9/25 · ROA 19% · ROE 30.9% · GNPA — · 68% evidenceValuation 8.1/20 · P/BV 5.32× · P/BV÷ROE 0.17 · 70% evidenceRelative strength 14.6/20 · Lead over its industry 8.6% · Lead over S&P 500 8.1% · 1 year -0.3% · 70% evidence · 8 of 12 weeks aheadExact sum: 28 + 19.9 + 8.1 + 14.6 = 70.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Arch Capital Group Ltd.ACGL · turning · Most evidence points up · 80% evidence70.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Income 0.4% · Profit 25.9% · 81% evidenceCapital efficiency 18.6/25 · ROA 3.6% · ROE 17.3% · GNPA — · 68% evidenceValuation 14.9/20 · P/BV 1.41× · P/BV÷ROE 0.08 · 70% evidenceRelative strength 15.5/20 · Lead over its industry 7.4% · Lead over S&P 500 7.4% · 1 year 23.6% · 100% evidence · 2 of 12 weeks aheadExact sum: 21.3 + 18.6 + 14.9 + 15.5 = 70.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Pelagos Insurance Capital Limited this pagePLGO · turning · Most evidence points up · 69% evidence67.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.8/35 · Income -3.6% · Profit — · 52% evidenceCapital efficiency 15.4/25 · ROA 2.3% · ROE 18.6% · GNPA — · 68% evidenceValuation 16.2/20 · P/BV 0.94× · P/BV÷ROE 0.05 · 70% evidenceRelative strength 17.1/20 · Lead over its industry 17.5% · Lead over S&P 500 17.9% · 1 year 45.4% · 100% evidence · 3 of 12 weeks aheadExact sum: 18.8 + 15.4 + 16.2 + 17.1 = 67.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Berkshire Hathaway Inc.BRK-A · breaking out · Evidence leans up · 80% evidence60.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.3/35 · Income 3.9% · Profit 36.3% · 81% evidenceCapital efficiency 11.5/25 · ROA 2.7% · ROE 5.6% · GNPA — · 68% evidenceValuation 5.7/20 · P/BV 1.44× · P/BV÷ROE 0.26 · 70% evidenceRelative strength 19.0/20 · Lead over its industry 8.9% · Lead over S&P 500 8.9% · 1 year 16.3% · 100% evidence · 4 of 12 weeks aheadExact sum: 24.3 + 11.5 + 5.7 + 19 = 60.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5The Hartford Insurance Group, Inc.HIG · basing · Evidence leans up · 80% evidence57.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.9/35 · Income 7% · Profit 34.7% · 81% evidenceCapital efficiency 17.5/25 · ROA 3% · ROE 17% · GNPA — · 68% evidenceValuation 12.6/20 · P/BV 1.85× · P/BV÷ROE 0.11 · 70% evidenceRelative strength 3.8/20 · Lead over its industry -4.4% · Lead over S&P 500 -4.5% · 1 year 6.7% · 100% evidence · 1 of 12 weeks aheadExact sum: 23.9 + 17.5 + 12.6 + 3.8 = 57.8 · What this means: Earnings are strong; relative strength in its sector is -4.4% and the one-year return is 6.7%.
  6. 6Aegon Ltd.AEG · quiet · Too little evidence to rank firmly · 56% evidence56.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.5/35 · Income — · Profit — · 15% evidenceCapital efficiency 15.8/25 · ROA 2.3% · ROE 76.9% · GNPA — · 68% evidenceValuation 16.3/20 · P/BV 1.25× · P/BV÷ROE 0.02 · 70% evidenceRelative strength 5.1/20 · Lead over its industry -1.6% · Lead over S&P 500 -1.4% · 1 year 12.9% · 100% evidence · 3 of 12 weeks aheadExact sum: 19.5 + 15.8 + 16.3 + 5.1 = 56.7 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  7. 7American International Group, Inc.AIG · turning · Evidence leans down · 80% evidence41.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 12.3/35 · Income -2.4% · Profit -7.3% · 81% evidenceCapital efficiency 10.7/25 · ROA 1.9% · ROE 7.5% · GNPA — · 68% evidenceValuation 8.6/20 · P/BV 0.97× · P/BV÷ROE 0.13 · 70% evidenceRelative strength 9.9/20 · Lead over its industry -1.3% · Lead over S&P 500 -1.4% · 1 year 6.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 12.3 + 10.7 + 8.6 + 9.9 = 41.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8International General Insurance Holdings Ltd.IGIC · quiet · Evidence leans down · 80% evidence37.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 9.9/35 · Income -1.9% · Profit -13.6% · 81% evidenceCapital efficiency 15.6/25 · ROA 2.9% · ROE 12.7% · GNPA — · 68% evidenceValuation 11.5/20 · P/BV 1.64× · P/BV÷ROE 0.13 · 70% evidenceRelative strength 0.5/20 · Lead over its industry -10.1% · Lead over S&P 500 -10.1% · 1 year 10.7% · 100% evidence · 1 of 12 weeks aheadExact sum: 9.9 + 15.6 + 11.5 + 0.5 = 37.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Sun Life Financial Inc.SLF · turning · Evidence leans down · 80% evidence35.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 11.6/35 · Income 4.1% · Profit 2.2% · 81% evidenceCapital efficiency 7.5/25 · ROA 0.5% · ROE 7.4% · GNPA — · 68% evidenceValuation 3.8/20 · P/BV 2.31× · P/BV÷ROE 0.31 · 70% evidenceRelative strength 12.3/20 · Lead over its industry 7.7% · Lead over S&P 500 8.1% · 1 year 40.1% · 100% evidence · 3 of 12 weeks aheadExact sum: 11.6 + 7.5 + 3.8 + 12.3 = 35.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Brookfield Wealth Solutions Ltd.BNT · basing · Most evidence points down · 68% evidence21.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 3.8/35 · Income -17.5% · Profit -84.2% · 81% evidenceCapital efficiency 4.3/25 · ROA -0.4% · ROE -13.8% · GNPA — · 68% evidenceValuation 9.8/20 · P/BV 0.8× · P/BV÷ROE — · 10% evidenceRelative strength 3.6/20 · Lead over its industry -7% · Lead over S&P 500 -7.2% · 1 year -5.8% · 100% evidence · 0 of 12 weeks aheadExact sum: 3.8 + 4.3 + 9.8 + 3.6 = 21.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Insurance - Diversified, all 10 compared on one page.

Which companies are close to Pelagos Insurance Capital Limited in size?

Pelagos Insurance Capital Limited is the 8th largest of 11 Insurance - Diversified companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Arch Capital Group, Brookfield Wealth Solutions and Aegon. Just below it: Exzeo Group, Inc., International General Insurance Holdings and Waterdrop Inc.

Insurance - Diversified companies close in size

  1. Arch Capital Group Ltd. $36 billion
  2. Brookfield Wealth Solutions Ltd. $15.4 billion
  3. Aegon Ltd. $12.8 billion
  4. Pelagos Insurance Capital Limited $2.3 billion
  5. Exzeo Group, Inc. $1.7 billion
  6. International General Insurance Holdings Ltd. $1 billion
  7. Waterdrop Inc. $363 million

All 11 Insurance - Diversified companies, largest first

Companies close in size in other industries

  1. The Boston Beer Company, Inc. $2.3 billion · Beverages - Brewers
  2. Intuitive Machines, Inc. $2.3 billion · Aerospace & Defense
  3. Pelagos Insurance Capital Limited $2.3 billion
  4. Septerna, Inc. $2.2 billion · Biotechnology
  5. Trulieve Cannabis Corp. $2.2 billion · Drug Manufacturers - Specialty & Generic

What else do people ask about Pelagos Insurance Capital Limited?

What were Pelagos Insurance Capital Limited Limited's latest quarterly results?

Pelagos Insurance Capital Limited reported total income of $650 M and net profit of $44.4 M for the Jun 2026 quarter. Income rose 10.3% and profit rose 125.4% compared with a year earlier. Earnings per share were $0.52 (as of 4 November 2026).

What is Pelagos Insurance Capital Limited Limited's market cap?

Pelagos Insurance Capital Limited's market capitalisation is $2.3 B at a stock price of $27.42. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Pelagos Insurance Capital Limited Limited performing?

Pelagos Insurance Capital Limited's share price has been rising for 43 weeks. In its latest quarter, income rose 10.3% and profit rose 125.4% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 2 weeks running (as of 4 November 2026).

Will Pelagos Insurance Capital Limited Limited's stock price go up?

This page does not forecast Pelagos Insurance Capital Limited's stock price. What it shows instead: the stock price is $27.42, and it has been rising for 43 weeks. Its P/BV of 1.0× is higher than 100% of its own last 3 years (as of 4 November 2026).

Where is Pelagos Insurance Capital Limited Limited in its business cycle?

Pelagos Insurance Capital Limited's FY25 net margin was 9.0%, against a 5-year range of 3.5% to 109.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 6.8%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Pelagos Insurance Capital Limited Limited story?

The main question: yearly earnings per share moved +115.3% while the share price moved +45.4%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Pelagos Insurance Capital Limited Limited a stock worth studying right now?

What the numbers show: Pelagos Insurance Capital Limited's earnings have grown faster than its share price. Earnings per share grew +115.3% in a year while the price moved +45.4%. The main open question: whether the price catches up with earnings that have already grown.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.